-
1
-
-
31344443966
-
Proteomic studies support the use of multi-product immunoassays to monitor host cell protein impurities
-
Krawitz DC, Forrest W, Moreno GT, Kittleson J, Champion KM. Proteomic studies support the use of multi-product immunoassays to monitor host cell protein impurities. Proteomics. 2006; 6: 94-110.
-
(2006)
Proteomics.
, vol.6
, pp. 94-110
-
-
Krawitz, D.C.1
Forrest, W.2
Moreno, G.T.3
Kittleson, J.4
Champion, K.M.5
-
2
-
-
0029009014
-
Host cell contaminant protein assay development for recombinant biopharmaceuticals
-
Eaton LC. Host cell contaminant protein assay development for recombinant biopharmaceuticals. J Chromatogr A. 1995; 705: 105-114.
-
(1995)
J Chromatogr A.
, vol.705
, pp. 105-114
-
-
Eaton, L.C.1
-
3
-
-
74849111728
-
Profiling of host cell proteins by two-dimensional difference gel electrophoresis (2D-DIGE): implications for downstream process development
-
Jin M, Szapiel N, Zhang J, Hickey J, Ghose S. Profiling of host cell proteins by two-dimensional difference gel electrophoresis (2D-DIGE): implications for downstream process development. Biotechnol Bioeng. 105; 2: 306-316.
-
Biotechnol Bioeng.
, vol.2
, pp. 306-316
-
-
Jin, M.1
Szapiel, N.2
Zhang, J.3
Hickey, J.4
Ghose, S.5
-
4
-
-
0001860867
-
-
New York: Plenum
-
Fryklund L, Hagerman M, Pavlu B, Skoog B, Wichman A. Methionyl Human Growth Hormone (Somatonorm): Purity and Properties-Human Growth Hormones. New York: Plenum; 1986: 257-266.
-
(1986)
Methionyl Human Growth Hormone (Somatonorm): Purity and Properties-Human Growth Hormones
, pp. 257-266
-
-
Fryklund, L.1
Hagerman, M.2
Pavlu, B.3
Skoog, B.4
Wichman, A.5
-
6
-
-
0034074086
-
Strategies for host cell protein analysis
-
Hoffman K. Strategies for host cell protein analysis. BioPharm. 2000; 13: 38-45.
-
(2000)
BioPharm.
, vol.13
, pp. 38-45
-
-
Hoffman, K.1
-
7
-
-
65549124409
-
Host cell proteins in biologics development: identification, quantitation and risk assessment
-
Wang X, Hunter AK, Mozier NM. Host cell proteins in biologics development: identification, quantitation and risk assessment. Biotechnol Bioeng. 2009; 103: 446-458.
-
(2009)
Biotechnol Bioeng.
, vol.103
, pp. 446-458
-
-
Wang, X.1
Hunter, A.K.2
Mozier, N.M.3
-
9
-
-
34250333460
-
Optimized removal of soluble host cell proteins for the recovery of met-human growth hormone inclusion bodies from Escherichia coli cell lysate using crossflow microfiltration
-
Venkiteshwaran A, Heider P, Matosevic S, Bogsnes A, Staby A, Sharfstein S, Belfort G. Optimized removal of soluble host cell proteins for the recovery of met-human growth hormone inclusion bodies from Escherichia coli cell lysate using crossflow microfiltration. Biotechnol Prog. 2007; 23: 667-672.
-
(2007)
Biotechnol Prog.
, vol.23
, pp. 667-672
-
-
Venkiteshwaran, A.1
Heider, P.2
Matosevic, S.3
Bogsnes, A.4
Staby, A.5
Sharfstein, S.6
Belfort, G.7
-
10
-
-
32344436889
-
Exploitation of the adsorptive properties of depth filters for host cell protein removal during monoclonal antibody purification
-
Yigzaw Y, Piper R, Tran M, Shukla AA. Exploitation of the adsorptive properties of depth filters for host cell protein removal during monoclonal antibody purification. Biotechnol Prog. 2006; 22: 288-296.
-
(2006)
Biotechnol Prog.
, vol.22
, pp. 288-296
-
-
Yigzaw, Y.1
Piper, R.2
Tran, M.3
Shukla, A.A.4
-
11
-
-
33847660116
-
Protein A chromatography for antibody purification
-
Hober S, Nord K, Linhult M. Protein A chromatography for antibody purification. J Chromatogr B. 2007; 848: 40-47.
-
(2007)
J Chromatogr B.
, vol.848
, pp. 40-47
-
-
Hober, S.1
Nord, K.2
Linhult, M.3
-
12
-
-
56249116669
-
Host cell protein clearance during Protein A chromatography: development of an improved column wash step
-
Shukla AA, Hinckley P. Host cell protein clearance during Protein A chromatography: development of an improved column wash step. Biotechnol Prog. 2008; 24: 1115-1121.
-
(2008)
Biotechnol Prog.
, vol.24
, pp. 1115-1121
-
-
Shukla, A.A.1
Hinckley, P.2
-
13
-
-
0026739326
-
Clusterin binds by a multivalent mechanism to the Fc and Fab regions of IgG
-
Wilson MR, Easterbrook-Smith SB. Clusterin binds by a multivalent mechanism to the Fc and Fab regions of IgG. Biochim Biophys Acta. 1992; 1159: 319-326.
-
(1992)
Biochim Biophys Acta.
, vol.1159
, pp. 319-326
-
-
Wilson, M.R.1
Easterbrook-Smith, S.B.2
-
15
-
-
0027164921
-
Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9
-
Tschopp J, Chonn A, Hertig S, French LE. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9. J Immunol. 1993; 151: 2159-2165.
-
(1993)
J Immunol.
, vol.151
, pp. 2159-2165
-
-
Tschopp, J.1
Chonn, A.2
Hertig, S.3
French, L.E.4
-
16
-
-
0037039346
-
Evidence that clusterin has discrete chaperone and ligand binding sites
-
Lakins JN, Poon S, Easterbrook-Smith SB, Carver JA, Tenniswood MP, Wilson MR. Evidence that clusterin has discrete chaperone and ligand binding sites. Biochemistry. 2002; 41: 282-291.
-
(2002)
Biochemistry.
, vol.41
, pp. 282-291
-
-
Lakins, J.N.1
Poon, S.2
Easterbrook-Smith, S.B.3
Carver, J.A.4
Tenniswood, M.P.5
Wilson, M.R.6
|